retatrutide phase 2 trial results weight loss 🚨 is out: 24.2% mean and a quarter lost >30%! Women lost more weight than men. #ADA2023 was like drinking from a fire hose for emerging anti-obesity Phase III retatrutide study demonstrates

For more information or to learn how to participate in clinical trials, call 305-842-2000 or visit www.omnicureresearch.com Novo Nordisk #Ozempic #KidneyHealth #DiabetesType2 #ClinicalResearch #OmnicureResearch #FLOWStudy #InnovationInHealth #ProtectYourKidneys To view or add a comment, sign in Today, more than 1 billion people live with obesity, a condition closely linked to cardiometabolic diseases such as type 2 diabetes and cardiovascular disease

Blood glucose monitoring becomes particularly important during this period, and your healthcare team may need to adjust other diabetes medications to maintain control

Chaphalkar Dr

for continued protection

### Step 5: Do Not Shake Gently Swirl or Roll Shaking causes peptide aggregation and can degrade retatrutide

The most common side effects are nausea/vomiting, diarrhea and constipation